gdc
Breast CancerSurvivorship

Do We Become Complacent Survivors After a Few Years of Cancer Remission?

Breast cancer survivor Ginger Modiri cautions those in remission to avoid becoming complacent and to keep up with their follow-up screenings.
October 2018 Vol 4 No 5
Ginger Modiri
CA realtor
San Juan Capistrano, CA
Breast cancer survivor
Ginger (center) surrounded by her family during Race for the Cure
Ginger (center) surrounded by her family during Race for the Cure, 9/2/18, in California.

Do we as cancer survivors tend to become complacent about our recovering health after several years? Is it easier to say, “Let sleeping dogs lie?”

I recently heard a “snip-it” from an article published by the National Comprehensive Cancer Network (or NCCN) titled “Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.”1

I was amazed to hear how many cancer survivors are failing to keep up with their long-term routine follow-up mammograms, according to the article.

Granted, most of us, including this survivor, don’t look forward to the scans, blood tests, or other types of testing. But we must keep reminding ourselves that follow-up is a necessary part of our continued recovery.

Surrounding ourselves in false reality may seem easier at the time, but dealing with the inevitable need for testing is a much healthier mindset.

Putting off routine service to our cars, computers, and appliances only leads to increased damage in deferred maintenance, usually costing us more financially.

Cutting years of life off ones’ machines is not the end of the world. Failing to adhere to strict routines regarding a survivor’s medical tests can prematurely be the end of the world for a human being.

Scheduling my mammograms, blood tests, colonoscopies, and other tests is pretty much a no-brainer; I tend to book those appointments around my birthday each year.

Why, you may ask? “It’s my birthday, and testing is the best gift I can give to myself.”

Reference

1. Ruddy KJ, Sangaralingham L, Freedman RA, et al. Adherence to guidelines for breast surveillance in breast cancer survivors. Journal of the National Comprehensive Cancer Network. 2018;16(5):526-534.

Recommended For You
Breast Cancer
Tukysa Improves Survival in Patients with HER2-Positive Breast Cancer that Has Spread to the Brain
By Meg Barbor, MPH
The new cancer drug Tukysa (tucatinib), when given in combination with Herceptin (trastuzumab) and capecitabine, dramatically improved outcomes for patients with HER2-positive advanced breast cancer that has spread to the brain, according to data presented by Nancy U. Lin, MD, Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, at the 2020 ASCO annual meeting.
Breast Cancer
Adding Kisqali to Endocrine Therapy Increases Survival in Patients with Advanced Breast Cancer and Visceral Metastases
By Meg Barbor, MPH
Metastatic breast cancer is cancer that has spread beyond the breast to other parts of the body. Visceral metastases refer to cancer that has spread to the internal organs of the body, specifically those within the chest (such as the heart or lungs) or abdomen (such as the liver, pancreas, or intestines).
Breast Cancer
Piqray plus Faslodex Effective in HR-Positive Advanced Breast Cancer with PIK3CA Mutation After Endocrine and Targeted Therapy
By Chase Doyle
Induction treatment with endocrine and targeted therapies has significantly improved survival for patients with hormone receptor (HR)-positive advanced breast cancer, but over time almost all patients stop responding to therapy.
Survivorship
Confronting Tough Questions After Cancer
By Sonia Su

As a 27-year-old, 3-time cancer alumna (I prefer this term to “survivor”), I have been reflecting on my relationships with my caregivers and loved ones.

Last modified: January 3, 2019

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country